Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival

Ming Yu Lien, Ti Hao Wang, Ching Yun Hsieh, Ming Hsui Tsai, Chun Hung Hua, Fu Ming Cheng, Wen Hui Chung, Chih Hsin Tang, Jason Chia-Hsun Hsieh*

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science